This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABT-288

AbbVie Inc.

Drug Names(s): ABT288

Description: ABT-288 is a histamine H3 antagonist. Blockade of central H3 receptors enhances the release of several neurotransmitters involved in cognition, and preclinical studies of H3 antagonists have shown improvements in a number of cognitive domains.


ABT-288 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug